Market-Moving News for July 24th
$HOTH
$PRG
$TSLA
Biotechnology: Pharmaceutical Preparations
Health Care
Diversified Commercial Services
Consumer Discretionary
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/12/2026 | $550.00 | Buy | Tigress Financial | |
| 1/30/2026 | $150.00 → $145.00 | Underweight | Analyst | |
| 1/12/2026 | $120.00 → $130.00 | Underweight | Wells Fargo | |
| 1/2/2026 | $444.00 → $439.00 | Hold | Truist | |
| 12/16/2025 | $50.00 | Buy | B. Riley Securities | |
| 12/8/2025 | $425.00 | Overweight → Equal-Weight | Morgan Stanley | |
| 11/21/2025 | $31.00 | Sell → Neutral | BTIG Research | |
| 10/29/2025 | $341.00 → $471.00 | Neutral | BofA Securities |
4 - Tesla, Inc. (0001318605) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
KBRA assigns preliminary ratings to five classes of notes issued by Purchasing Power Funding 2026-A, LLC ("PPWR 2026-A"), a $225.00 million consumer installment receivable ABS transaction. PPWR 2026-A is a revolving ABS securitization with an initial securitization value of approximately $256.1 million and is collateralized by a pool of retail installment sales contracts ("Receivables") originated by Purchasing Power, LLC (the "Company" or "Purchasing Power"). Founded in 2001, Purchasing Power is an Atlanta, GA-based provider of an organization-sponsored payroll purchase program. On January 2, 2026, the Company was acquired for approximately $420 million by PROG Holdings, Inc. (NYSE:PRG)
In a head-to-head preclinical comparison, HT-VA co-developed with the United States Veterans Administration GDNF demonstrated superior efficacy compared with semaglutide (the active ingredient in Wegovy®️ and Ozempic®️) across key metrics, including weight stabilization, glucose tolerance, liver weight reduction, and adipose tissue control—particularly in female models NEW YORK, Feb. 10, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company developing innovative therapies for unmet medical needs, today announced compelling preclinical data from its VA-backed study on glial cell-derived neurotrophic factor (GDNF) as a novel treatment for obesi
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer patients with significant unmet needs, today announced over the last several days investors have contacted the company re our exposure to digital assets such as Bitcoin , Solana and Ethereum. Hoth holds no cryptocurrency assets, and its maximum exposure never reached more than $350,000 USD over the last year. Hoth continues to execute on its HT-001 clinical trial and continues progressing its pipeline to further clinical trials in both oncology and obesity.
4 - Tesla, Inc. (0001318605) (Issuer)
4 - PROG Holdings, Inc. (0001808834) (Issuer)
4 - PROG Holdings, Inc. (0001808834) (Issuer)
Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00
Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously
Wells Fargo reiterated coverage of Tesla with a rating of Underweight and set a new price target of $130.00 from $120.00 previously
10-K - Tesla, Inc. (0001318605) (Filer)
8-K - Tesla, Inc. (0001318605) (Filer)
8-K - Hoth Therapeutics, Inc. (0001711786) (Filer)
This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it
Company Expands IP Portfolio While Advancing Clinical Innovation in Oncology Supportive Care Case Study and Interim Clinical Trial Results Will Be Discussed NEW YORK, June 5, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a clinical-stage biopharmaceutical company pioneering breakthrough therapies to improve the lives of patients, today announced a Key Opinion Leader (KOL) event showcasing HT-001, its novel topical therapeutic, designed to treat debilitating skin toxicities caused by EGFR inhibitor cancer therapies. These common treatment-limiting side effects—suc
PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build, today announced the appointment of Robert Julian and Daniela Mielke to its Board of Directors. "Robert and Daniela are recognized leaders in industries that are especially relevant to PROG Holdings. Robert's consumer retail and e-commerce financial expertise, as well as Daniela's leadership in digital payments, fintech and e-commerce, will make them both highly valuable additions to our Board," said Ray Robinson, Chairman of PROG Holdings. "We're pleased to welcome Robert and Daniela as our newest independent directors," said Steve Michaels, PROG Holdings' P
PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Purchasing Power, Four Technologies, and Build, is scheduled to release financial results for the fourth quarter of 2025 on Wednesday, February 18, 2026 prior to the market open. The Company has also scheduled a live webcast for February 18, 2026 at 8:30 A.M. ET to discuss its financial results for the fourth quarter of 2025. The webcast can be accessed via the below link, or through the Events & Presentations section of the PROG Holdings investor relations website, https://investor.progholdings.com. Webcast Link: https://edge.media-server.com/mmc/p/6r2ad2sv About PROG Holdings, Inc. PROG Holdings,
In the fourth quarter, we produced over 434,000 vehicles, delivered over 418,000 vehicles and deployed 14.2 GWh of energy storage products – a record for deployments. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q4 2025 Production Deliveries Subject to operating lease accounting Model 3/Y 422,652 406,585 3% Other Models 11,706 11,642 5% Total 434,358 418,227 3% 2025 Production Deliveries Model 3/Y 1,600,767 1,585,279 Other Models 53,900 50,850
Expands PROG Holdings' growing ecosystem through a new, scalable customer acquisition channel that complements its existing payment solutions Creates access to an employee-focused consumer base with limited overlap across existing PROG customers, enabling substantial expansion of current and new offerings Generates new employer-client and partner opportunities Advances PROG Holdings' long-term growth strategy to provide transparent and inclusive payment options to near- and below-prime consumers PROG Holdings, Inc. ((PRG), the fintech holding company for Progressive Leasing, Four Technologies, and Build, today announced it has reached an agreement to acquire Purchasing Power, a lea
SC 13G/A - PROG Holdings, Inc. (0001808834) (Subject)
SC 13G/A - PROG Holdings, Inc. (0001808834) (Subject)
SC 13G/A - PROG Holdings, Inc. (0001808834) (Subject)